Prochlorperazine and Decitabine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Prochlorperazine (prochlorperazine) and Decitabine (decitabine). Common drug interactions include leukopenia among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Prochlorperazine and Decitabine. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Prochlorperazine?

Prochlorperazine has active ingredients of prochlorperazine. It is often used in nausea. eHealthMe is studying from 14,632 Prochlorperazine users. Check the latest studies of Prochlorperazine.

What is Decitabine?

Decitabine has active ingredients of decitabine. eHealthMe is studying from 4,605 Decitabine users. Check the latest studies of Decitabine.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 03, 2026

24 people who take Prochlorperazine and Decitabine together, and have interactions are studied.

Prochlorperazine and Decitabine drug interactions.

What are the common drug interactions of Prochlorperazine and Decitabine, by gender? *:

female:

Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Abdominal pain upper
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Cardiac arrest
Disease progression
Drug ineffective
Pyrexia (fever)
White blood cell count decreased

male:

Death
Dehydration (dryness resulting from the removal of water)
Aortic valve stenosis (narrowing of the aortic valve)
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Benign prostatic hyperplasia (benign enlargement of the prostate)
Chronic kidney disease
Chronic left ventricular failure (long lasting functional impairment of left ventricle of heart)
Chronic leukaemia (long lasting blood cell cancer)
Confusional state

What are the common drug interactions of Prochlorperazine and Decitabine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Leukopenia (less number of white blood cells in blood)
Neutropenia (an abnormally low number of neutrophils)
Sepsis (a severe blood infection that can lead to organ failure and death)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
Asthenia (weakness)
Cardiac arrest
Confusional state
Drug ineffective
Eye disorder

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 15 people, 62.50%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 4 people, 16.67%
Osteoporosis (bones weak and more likely to break): 3 people, 12.50%
High Blood Pressure: 3 people, 12.50%
Depression: 3 people, 12.50%
Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Prochlorperazine and Decitabine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously